Medindia

X

Frost & Sullivan: Escalating Costs of Drug Development Drive the Pharmaceutical Companies to Tap Opportunities in Emerging Markets

Thursday, June 24, 2010 General News J E 4
Advertisement

Contact:

Katja Feick

Corporate Communications – Europe

P: +49 (0) 69 7703343

E: katja.feick@frost.com

http://www.frost.com

Twitter: twitter.com/frost_sullivan

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Diabetes Care Devices Market in Brazil, Russia, In...
S
Awarepoint to Present the Advantages and Ease of E...